-
Recent reports indicate that up to 20% of patients using popular obesity medications like Wegovy and Mounjaro may not experience significant weight loss. Experts emphasize the variability in individual responses to these treatments, urging realistic expectations among users. This highlights the complexities of obesity treatment and the need for personalized approaches.
-
Robert F. Kennedy Jr.'s nomination as Health Secretary has led to significant stock declines in vaccine and pharmaceutical companies. His history of vaccine skepticism raises concerns about regulatory changes and investment in the biotech sector, particularly affecting companies like Moderna and Pfizer.
-
A recent clinical trial reveals that benralizumab, an injection targeting eosinophils, is more effective than traditional steroid treatments for asthma and COPD flare-ups. This breakthrough could transform care for millions, marking the first significant advancement in 50 years.